Umang Swami, MD, MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Astellas
    Topic:
    consultancy
    Date added:
    06/27/2022
    Date updated:
    05/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Exelixis
    Topic:
    consultancy
    Date added:
    06/27/2022
    Date updated:
    05/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Seattle Genetics
    Topic:
    consultancy
    Date added:
    06/27/2022
    Date updated:
    05/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Gilead
    Topic:
    consultancy
    Date added:
    05/08/2023
    Date updated:
    05/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    ImVax
    Topic:
    consultancy
    Date added:
    05/08/2023
    Date updated:
    05/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Sanofi
    Topic:
    consultancy
    Date added:
    05/08/2023
    Date updated:
    05/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    AstraZeneca
    Topic:
    consultancy
    Date added:
    05/08/2023
    Date updated:
    05/02/2024
Return to Summit on Cancer Health Disparities (SCHD24)